-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-235-section-1-tables-1-2.pdf
September 24, 2018 - Codes
Table 1: Taxonomy Codes by Specialty
Specialty Taxonomy Code
Cardiology Cardiovascular Disease … and Neurotology 207YX0901X
Otolaryngology/Facial Plastic Surgery 207YX0905X
Pulmonology Pulmonary Disease … Mass Immunization Center 60
Comprehensive Outpatient Rehabilitation Facility 62
End-stage Renal Disease
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/funding/fund-opps/state-level-cpcq.pdf
December 01, 2019 - Reporting measurements of practice
performance on cardiovascular disease
prevention measures (such as … aspirin for
patients at risk for ischemic vascular disease)
for comparison with their peers
10. … Setting goals and benchmarking rates of
performance quality on cardiovascular disease
prevention measures … Customizing the implementation of
cardiovascular disease prevention care changes
to the practice
12.
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/toolkits/healthplan-key-drive-diagram.pdf
January 29, 2021 - sickle cell
anemia
Activate Care
Management Strategies
• Pediatric members with sickle cell disease … ,
child care for siblings during visits)
• Care managers receive education regarding sickle cell disease … sickle cell anemia
• Health plan staff develop a registry of pediatric members with
sickle cell disease … Health plan staff provide training and educational
information to providers regarding sickle cell disease
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/evidencenow/results/research/practice-survey-6mon-post-intervention-nw.pdf
February 27, 2019 - cardiovascular preventive care
(e.g., prescribing aspirin for patients at risk for ischemic vascular disease … new approach to care
Reporting measurements of practice performance on
cardiovascular disease … prevention measures (such as
aspirin for patients at risk for ischemic vascular disease)
for comparison … peers
Setting goals and benchmarking rates of performance
quality on cardiovascular disease … is the highest, what is the priority your practice’s leadership places on
improving cardiovascular disease
-
www.talkingquality.ahrq.gov/evidencenow/projects/heart-health/about/cooperatives/virginia.html
March 01, 2021 - care practices have the evidence they need to help their patients adopt the ABCS of cardiovascular disease … –2018
Region and Population
Virginia has a population of more than 8.4 million people. 1 Heart disease … Northern, Central, and Eastern Virginia, some of the highest age-adjusted death rates due to heart disease … Centers for Disease Control and Prevention. Interactive Atlas of Heart Disease and Stroke. … Centers for Disease Control and Prevention. Interactive Atlas of Heart Disease and Stroke.
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-213-section-5-table-4.pdf
January 01, 2012 - Section 5, Table 4
Table 4: Evidence Supporting Hydroxyurea Treatment for Children with Sickle Cell Disease … The
Management of Sickle
Cell Disease. National
Institutes of Health.
Bethesda, MD, 2002. … Health
supervision for children
with sickle cell disease.
Pediatrics 2002;
109(3):526‐535. … (p. 933)
for sickle cell disease.
Ann Intern Med 2008;
148(12): 932‐938. … Hydroxyurea for children
with sickle cell disease.
Pediatr Clin North Am
2008; 55(2):483‐501.
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/evidencenow/cooperatives/evidencenow-executive-summary-va.pdf
November 01, 2017 - care practices have the evidence they need to help their patients adopt the
ABCS of cardiovascular disease … Accessed August 16, 2017.
3 Centers for Disease Control and Prevention. … Interactive Atlas of Heart Disease and Stroke.
https://nccd.cdc.gov/DHDSPAtlas/Reports.aspx. … Accessed August 16, 2017.
5 Centers for Disease Control and Prevention. … Interactive Atlas of Heart Disease and Stroke.
https://nccd.cdc.gov/DHDSPAtlas/Reports.aspx.
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/patient-safety/reports/issue-briefs/dxsafety-probabilistic-thinking.pdf
September 01, 2022 - Simple language includes discussing chance or
probability of disease or diseases, with numerical quantification … history and
physical examination, each element of which informs adjustment of the probabilities of diseases … understanding of prevalence and probabilistic reasoning by rewarding learners for suggesting rare diseases … The number of positive tests that
would occur in patients with disease and those without disease could … This exercise will highlight the incidence of common diseases in
various populations, train intuition
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-157-section-7b.pdf
June 30, 2009 - stratified by special
healthcare needs status, January 1, 2008-June 30, 2009.
6 Months
Chronic Disease … 18355
UT
0.9306
(0.9232,0.9374)
5069
0.8740
(0.8686,0.8792)
15154
12 Months
Chronic Disease … 18 Months
Chronic Disease
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-156-section-7b.pdf
June 30, 2009 - stratified by special healthcare
needs status, January 1, 2008-June 30, 2009.
6 Months
Chronic Disease … 82888
UT
0.8450
(0.8386,0.8512)
12817
0.7546
(0.7511,0.7580)
59935
12 Months
Chronic Disease … 18 Months
Chronic Disease
-
www.talkingquality.ahrq.gov/cahps/surveys-guidance/ich/index.html
November 01, 2023 - Hemodialysis Survey
The CAHPS In-Center Hemodialysis Survey asks adults with end-stage renal disease … Dialysis facilities and End-Stage Renal Disease Networks (known simply as Networks) use this tool to
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-133-section-2-tech-specs.pdf
January 01, 2011 - 104 2y Other and ill-defined heart
disease
103 2y Pulmonary heart disease
96 2y Heart valve disorders … 157 2y Acute and unspecified
renal failure
161 2y Other diseases of kidney
and ureters
5890 … lung field
7942 Nonspecific abnormal results of pulmonary
function study
V126 Personal history of diseases … Personal history of pneumonia (recurrent)
V1269 Personal history of other diseases of
respiratory system … Count the number of visits for each of the high risk pregnancies with
HIV disease to an infectious disease
-
www.talkingquality.ahrq.gov/questions/resources/diagnosis/support.html
November 01, 2020 - Information
Next Steps After Your Diagnosis offers general advice for people with almost any disease … Every person is different, of course, and every person's disease or condition will affect them differently … research referred to in this publication focuses on cancer, it likely is relevant to people with other diseases
-
www.talkingquality.ahrq.gov/hai/tools/ambulatory-care/cap-ed-setting-slides.html
January 01, 2018 - Centers for Disease Control and Prevention. Centers for Disease Control and Prevention (CDC). … Clinical Infectious Diseases 2007; 44, S27-S72. … Clinical Infectious Diseases 2007; 44, S27-S72. … Clinical Infectious Diseases 2007; 44, S27-S72. … Clinical Infectious Diseases 2007; 44, S27-S72.
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0138-section-6a.pdf
December 01, 2013 -
Q‐METRIC Sickle Cell Disease … Measure 3: Appropriate Antibiotic Prophylaxis for Children with Sickle
Cell Disease
Graphics for … Reliability
Figure 1: Provision of Antibiotic Prescriptions, 300‐Day Rate, for Children with Sickle Cell Disease …
Figure 2: Provision of Antibiotic Prescriptions, 350‐Day Rate, for Children with Sickle Cell Disease …
Table 5: Sickle Cell Disease
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-213-section-6-tables-5-6.pdf
January 24, 2019 - CHIPRA 213: Section 6, Tables 5 and 6
Table 5: Agreement and Kappa Statistics for Sickle Cell Disease … Table 6: Anticipatory Guidance Regarding Hydroxyurea Treatment for Children with Sickle
Cell Disease
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/chipra-medical-home-academyhealth.pdf
December 12, 2015 - Complex Chronic Disease
2. Non-Complex Chronic Disease
3. … Without Chronic Disease
• Our analysis of preventable ED use compared categories
1 and 2 (any chronic … disease) to 3 (no chronic disease)
Analytic Methods
• Outcome: Binary variable, had/did not have … ED visit 84.3% 87.6%
Cohort size 6,906 3,163
Results (Question 2) – By PMCA Category
(Chronic Disease … No Chronic Disease)
• Longitudinal analysis, unadjusted percentages
Longitudinal
-
www.talkingquality.ahrq.gov/evidencenow/heart-health/aspirin/treatment.html
August 01, 2018 - Secondary and Primary Prevention of ASCVD
Resource description: This presentation explains heart disease … and the use of aspirin for primary and secondary prevention of heart disease.
-
www.talkingquality.ahrq.gov/evidencenow/heart-health/cholesterol/detailing.html
September 01, 2018 - statins for cholesterol management in high-risk groups, including patients with prior cardiovascular disease … , diabetes, high LDL cholesterol, or elevated risk of heart disease.
-
www.talkingquality.ahrq.gov/evidencenow/heart-health/aspirin/prevention.html
September 01, 2018 - Prevention and Risk Reduction Therapy for Patients with Coronary and Other Atherosclerotic Vascular Disease … guideline, published in Circulation in 2011, for prescribing aspirin for secondary prevention of heart disease